Department of Medical Sciences, Clinical Chemistry, Uppsala University Hospital, Uppsala, Sweden.
External Quality Assessment for Clinical Laboratory Investigations (Equalis), Uppsala, Sweden.
Clin Chem Lab Med. 2019 May 27;57(6):838-844. doi: 10.1515/cclm-2018-0670.
Background Creatinine measurement for estimation of glomerular filtration rate (GFR) is a frequently used laboratory test. Differences in analytic creatinine methods have caused large inter-laboratory variation. International and national standardization efforts have been made in the last decade. Methods This study describes the results of the standardization efforts in Sweden by summarizing data for creatinine concentration in blood plasma in the Equalis quality assessment program during 1996-2014. Results Non-compensated Jaffe methods dominated in 1996-2001 (91 of 103 laboratories; 90%) and were then gradually replaced by either compensated Jaffe methods or enzymatic creatinine methods. In 2014 a majority of Swedish hospital laboratories (139 of 159; 87%) used enzymatic methods. The reported mean creatinine value by the Swedish laboratories was about 10 μmol/L higher than the isotope dilution mass spectrometry (IDMS) assured reference value in 2003, but consistent with the reference value from 2009 to 2014. The inter-laboratory CV was 7%-9% for creatinine values until 2007, and thereafter gradually decreased to about 4%-5% in 2014. Conclusions The introduction of enzymatic methods in Swedish laboratories has contributed to achieving a low inter-laboratory variation. Also, the reported values are lower for enzymatic methods compared to Jaffe methods, and the values obtained with enzymatic methods were consistent with IDMS certified values established at reference laboratories. Thus, many Swedish hospital laboratories reported 10 μmol/L lower, and more true, creatinine concentrations in 2012 than in 2003, which may cause bias in longitudinal studies.
背景 肌酐测定用于肾小球滤过率(GFR)的估计,是一种常用的实验室检测。由于分析肌酐方法的差异,导致了实验室间的巨大变异。在过去十年中,已经进行了国际和国家标准化的努力。
方法 本研究通过总结 1996-2014 年期间 Equalis 质量评估计划中血浆肌酐浓度的数据,描述了瑞典标准化工作的结果。
结果 在 1996-2001 年,非补偿 Jaffe 方法占主导地位(103 个实验室中有 91 个;90%),随后逐渐被补偿 Jaffe 方法或酶法肌酐方法取代。2014 年,瑞典大多数医院实验室(159 个中有 139 个;87%)使用酶法。瑞典实验室报告的平均肌酐值比 2003 年同位素稀释质谱法(IDMS)保证的参考值高约 10 μmol/L,但与 2009 年至 2014 年的参考值一致。直到 2007 年,实验室间的 CV 为肌酐值的 7%-9%,此后逐渐下降到 2014 年的约 4%-5%。
结论 瑞典实验室中酶法的引入有助于实现低实验室间变异。此外,与 Jaffe 方法相比,酶法报告的肌酐值较低,并且用酶法获得的值与参考实验室建立的 IDMS 认证值一致。因此,许多瑞典医院实验室在 2012 年报告的肌酐浓度比 2003 年低 10 μmol/L,这可能会导致纵向研究产生偏差。